Is digital therapeutics innovation enough for a sustainable future?
Treatments emerging from the digital therapeutics space were once …
Newsletters and Deep Dive digital magazine
Treatments emerging from the digital therapeutics space were once …
A phase 3 trial of MSD’s anti-TIGIT antibody vibostolimab and PD-1 …
Takeda has made a strong play for a stake in the Alzheimer’s disease …
Monitoring of heart failure patients in their homes using a wearable …
Sanofi will invest more than €1 billion ($1.08 billion) in new …
Leela Barham looks at the speediness of NICE’s technology appraisals …
Clinical trials historically struggled with several key …
Moderna’s first attempt to expand its commercial activities beyond …
The first person to receive a transplant of a kidney from a pig has …
Three years after turning it down for being too expensive, NICE has …
It’s no secret that the UK life sciences sector is facing skills …
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this …